135 related articles for article (PubMed ID: 2989605)
1. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases.
Bradbear RA; Bain C; Siskind V; Schofield FD; Webb S; Axelsen EM; Halliday JW; Bassett ML; Powell LW
J Natl Cancer Inst; 1985 Jul; 75(1):81-4. PubMed ID: 2989605
[TBL] [Abstract][Full Text] [Related]
2. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.
Fracanzani AL; Conte D; Fraquelli M; Taioli E; Mattioli M; Losco A; Fargion S
Hepatology; 2001 Mar; 33(3):647-51. PubMed ID: 11230745
[TBL] [Abstract][Full Text] [Related]
3. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.
Geier D; Hebert B; Potti A
Anticancer Res; 2002; 22(6B):3797-9. PubMed ID: 12552996
[TBL] [Abstract][Full Text] [Related]
4. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
5. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
[TBL] [Abstract][Full Text] [Related]
6. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.
Deutsch M; Papatheodoridis GV; Tzakou A; Hadziyannis SJ
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):5-9. PubMed ID: 18090982
[TBL] [Abstract][Full Text] [Related]
7. Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease.
Ueno Y; Moriyama M; Uchida T; Arakawa Y
Hepatology; 2001 Feb; 33(2):357-62. PubMed ID: 11172337
[TBL] [Abstract][Full Text] [Related]
8. Iron in the pathogenesis of hepatocellular carcinoma.
Fargion S; Piperno A; Fracanzani AL; Cappellini MD; Romano R; Fiorelli G
Ital J Gastroenterol; 1991 Dec; 23(9):584-8. PubMed ID: 1662094
[TBL] [Abstract][Full Text] [Related]
9. Hepatic and extrahepatic malignancies in primary biliary cirrhosis.
Floreani A; Baragiotta A; Baldo V; Menegon T; Farinati F; Naccarato R
Hepatology; 1999 May; 29(5):1425-8. PubMed ID: 10216125
[TBL] [Abstract][Full Text] [Related]
10. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
[TBL] [Abstract][Full Text] [Related]
11. No association between genetic hemochromatosis and alpha1-antitrypsin deficiency.
Fargion S; Bissoli F; Fracanzani AL; Suigo E; Sergi C; Taioli E; Ceriani R; Dimasi V; Piperno A; Sampietro M; Fiorelli G
Hepatology; 1996 Nov; 24(5):1161-4. PubMed ID: 8903392
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.
Jones DE; Metcalf JV; Collier JD; Bassendine MF; James OF
Hepatology; 1997 Nov; 26(5):1138-42. PubMed ID: 9362353
[TBL] [Abstract][Full Text] [Related]
13. Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases.
Mukaiya M; Nishi M; Miyake H; Hirata K
Hepatogastroenterology; 1998; 45(24):2328-32. PubMed ID: 9951917
[TBL] [Abstract][Full Text] [Related]
14. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
16. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark.
Sorensen HT; Friis S; Olsen JH; Thulstrup AM; Mellemkjaer L; Linet M; Trichopoulos D; Vilstrup H; Olsen J
Hepatology; 1998 Oct; 28(4):921-5. PubMed ID: 9755226
[TBL] [Abstract][Full Text] [Related]
17. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients.
Takano S; Yokosuka O; Imazeki F; Tagawa M; Omata M
Hepatology; 1995 Mar; 21(3):650-5. PubMed ID: 7875662
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
[TBL] [Abstract][Full Text] [Related]
19. Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II).
Inoue M; Kurahashi N; Iwasaki M; Tanaka Y; Mizokami M; Noda M; Tsugane S;
Cancer Causes Control; 2009 Jul; 20(5):741-50. PubMed ID: 19115074
[TBL] [Abstract][Full Text] [Related]
20. [Survival and development of neoplasms in 56 patients with idiopathic hemochromatosis].
Fraquelli M; Mandelli C; Cesarini L; Barisani D; Bianchi PA; Conte D
Ann Ital Med Int; 1992; 7(1):26-9. PubMed ID: 1326311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
